Experienced in Autosomal Recessive Hypotrichosis

Flavio A. Cadegiani

Brasilia, DF, BR 
Experienced in Autosomal Recessive Hypotrichosis
Brasilia, DF, BR 
OverviewLocationsClinical Research

Overview

Flavio Cadegiani practices in Brasilia, Brazil. Mr. Cadegiani is rated as an Experienced expert by MediFind in the treatment of Autosomal Recessive Hypotrichosis. His top areas of expertise are COVID-19, Obesity, Severe Acute Respiratory Syndrome (SARS), and Autosomal Recessive Hypotrichosis.

His clinical research consists of co-authoring 47 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 1 clinical trial in the study of Autosomal Recessive Hypotrichosis.

Gender
Male

Locations

Brasilia, DF, Brazil
Other Locations
Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Anti-Androgen Treatment for COVID-19
Anti-Androgen Treatment for COVID-19
Enrollment Status: Completed
Publish Date: December 10, 2021
Intervention Type: Other, Drug
Study Phase: Not Applicable
Proxalutamide Treatment for Hospitalized COVID-19 Patients
Proxalutamide Treatment for Hospitalized COVID-19 Patients
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Drug
Study Drug: Proxalutamide
Study Phase: Phase 3
View 1 Less Clinical Trial

47 Total Publications

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects.
Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects.
Journal: Cureus
Published: August 31, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cadegiani's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile